Calquence (acalabrutinib)

pCPA File Number: 21416
Negotiation Status:
Under consideration for negotiation
Indication(s):
Chronic Lymphocytic Leukemia (CLL) (previously untreated)
Sponsor/Manufacturer:
ASTRAZENECA CANADA INC
CADTH Project Number:
PC0210-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded:
Not Applicable